Human cardiac frozen tissue sections are histological specimens prepared from fresh-frozen (snap-frozen) cardiac tissue obtained from anatomically defined regions of the heart, including the atria, ventricles, interventricular septum, valves, and, when available, components of the cardiac conduction system. Rapid freezing minimizes degradation of RNA, proteins, lipids, and many enzymatic activities while preserving DNA integrity, tissue architecture, and cellular composition, making frozen sections particularly valuable for molecular and spatial analyses. These specimens are widely used in cardiovascular research to investigate the cellular and molecular mechanisms underlying normal cardiac physiology, myocardial remodeling, ischemic injury, cardiomyopathies, heart failure, inherited cardiac disorders, and inflammatory heart diseases. Fresh-frozen cardiac tissue is particularly well suited for applications requiring high-quality nucleic acids and proteins, supporting comprehensive molecular characterization of healthy and diseased myocardium.

Key Features

• Fresh-Frozen Tissue Preservation – Prepared from snap-frozen human cardiac tissue to preserve molecular integrity for downstream research applications.

• High Molecular Quality – Preserves RNA quality, DNA integrity, proteins, lipids, and many enzymatic activities for molecular and biochemical analyses.

• Preserved Tissue Architecture – Retains native cardiac histology and cellular composition for histological, spatial, and imaging studies.

• Anatomically Defined Specimens – Available from multiple cardiac regions, including disease-specific specimens when available.

• Broad Research Compatibility – Compatible with a wide range of molecular, histological, spatial biology, and imaging workflows.

Common Research Applications

• Immunofluorescence (IF) and immunohistochemistry (IHC).

• Spatial transcriptomics, RNA sequencing (RNA-seq), and gene expression profiling.

• Proteomics, metabolomics, and lipidomics.

• In situ hybridization (ISH), including RNA-based assays, and multiplex molecular imaging.

• Biomarker discovery, spatial cell atlas studies, and comparative analyses of healthy and diseased myocardium.